Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Maxim Group Transfers Coverage on Thompson Creek Metals (TC) at Buy
-
Redefy Holdings, Inc. Completes Share Exchange Transaction and Becomes Publicly Traded Entity
-
Redefy Holdings, Inc. Completes Share Exchange Transaction and Becomes Publicly Traded Entity
-
Maxim Group Downgrades Xtant Medical (XTNT) to Hold
-
AGBA Acquisition Limited Announces Closing of $46.0 million Initial Public Offering, including Full Exercise of Underwriters' Over-allotment Option
-
AGBA Acquisition Limited Announces Pricing of $40 Million Initial Public Offering
-
H.C. Wainwright and Maxim Group Estimate Nearly 95% Upside for CODX
-
H.C. Wainwright and Maxim Group Estimate Nearly 95% Upside for CODX
-
Maxim Group Downgrades Control4 Corporation (CTRL) to Hold
-
The Joint Corp (JYNT) PT Raised to $25 at Maxim Group
-
Powerbridge Technologies Announces Full Exercise and Closing of Underwriters Over-Allotment Option in Initial Public Offering
-
Powerbridge Technologies Announces Full Exercise and Closing of Underwriters Over-Allotment Option in Initial Public Offering
-
Knightscope Hires Maxim Group LLC
-
Zosano Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares
-
Seanergy Maritime (SHIP) Prices 4.2M Unit Offering at $3.40/Unit
-
Medalist Diversified REIT (MDRR) Prices 1.667M Share Common Offering at $4.80/Sh
-
Seanergy Maritime Holdings Corp. Announces Pricing of $14.3 Million Underwritten Public Offering
-
Medalist Diversified REIT Announces Pricing of Public Offering of Common Stock
-
DelMar Pharmaceuticals Announces Key Dates and Timeline for Stockholder Participation in Rights Offering
-
Maxim Group Downgrades Potbelly Corp (PBPB) to Hold
-
Nxt-ID, Inc. Completes $16.5 Million Long-term Debt Refinancing
-
Maxim Group Assumes ContraFect Corp. (CFRX) at Buy
-
Maxim Group Starts Craft Brew Alliance (BREW) at Buy
-
Horizon Technology Finance (HRZN) PT Lowered to $13 at Maxim Group
-
Pitney Bowes (PBI) PT Lowered to $9 at Maxim Group
-
Maxim Group Starts Avid Technology (AVID) at Buy
-
Maxim Group Downgrades BeyondSpring (BYSI) to Hold
-
Atlantic Tele-Network (ATNI) PT Lowered to $71 at Maxim Group
-
Reebonz Announces Exercise of Over-Allotment Option
-
Reebonz Announces Exercise of Over-Allotment Option
-
Avalon GloboCare Announces $6 Million Registered Direct Offering with Institutional Investors
-
Chipotle Mexican Grill (CMG) PT Raised to $635 at Maxim Group
-
Latest subpoena sours Chipotle's quarterly beat
-
Domino's Pizza (DPZ) PT Raised to $315 at Maxim Group
-
Maxim Group Starts Chicken Soup for the Soul (CSSE) at Buy
-
Moleculin Biotech (MBRX) Prices 9.375M Unit Offering at $1.60/Unit
-
Moleculin Announces $15.0 Million Registered Direct Offering
-
Maxim Group Downgrades Dunkin' Brands (DNKN) to Hold
-
Maxim Group Starts TOP Ships (TOPS) at Buy
-
Envision Solar Announces Closing of Upsized $12.0 Million Public Offering
-
Maxim Group Starts Graham Corporation (GHM) at Buy
-
Pre-Open Stock Movers 04/17: (SFS) (QCOM) (HOLI) Higher; (S) (BK) (NTRA) Lower (more...)
-
UPDATE: Maxim Group Starts Zosano Pharma (ZSAN) at Buy
-
Maxim Group Starts South Jersey Industries, Inc. (SJI) at Buy
-
PlacementTracker Publishes Q1 2019 PIPE and Private Placement Markets League Tables
-
Envision Solar Announces Pricing of Upsized $12.0 Million Public Offering and Uplisting to Nasdaq
-
Reebonz Holding (RBZ) Prices $10.8 Million Underwritten Public Offering of Ordinary Shares, Warrants
-
Reebonz Announces Pricing of $10.8 Million Underwritten Public Offering
-
Reebonz Announces Pricing of $10.8 Million Underwritten Public Offering
-
PAVmed (PAVM) Announces $1.6M Registered Direct Offering of its Common Stock


